中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共4条，第1-4条 帮助

限定条件        
已选(0)清除 条数/页：   排序方式：
Multiparametric MRI-based radiomics analysis for the prediction of breast tumor regression patterns after neoadjuvant chemotherapy 期刊论文
TRANSLATIONAL ONCOLOGY, 2020, 卷号: 13, 期号: 11, 页码: 8
作者:  Zhuang, Xiaosheng;  Chen, Chi;  Liu, Zhenyu;  Zhang, Liulu;  Zhou, Xuezhi;  Cheng, Minyi;  Ji, Fei;  Zhu, Teng;  Lei, Chuqian;  Zhang, Junsheng;  Jiang, Jingying;  Tian, Jie;  Wang, Kun
收藏  |  浏览/下载：233/0  |  提交时间：2021/01/07
Multi-Habitat Based Radiomics for the Prediction of Treatment Response to Concurrent Chemotherapy and Radiation Therapy in Locally Advanced Cervical Cancer 期刊论文
FRONTIERS IN ONCOLOGY, 2020, 卷号: 10, 页码: 8
作者:  Fang, Mengjie;  Kan, Yangyang;  Dong, Di;  Yu, Tao;  Zhao, Nannan;  Jiang, Wenyan;  Zhong, Lianzhen;  Hu, Chaoen;  Luo, Yahong;  Tian, Jie
Adobe PDF(730Kb)  |  收藏  |  浏览/下载：310/50  |  提交时间：2020/06/22
cervical cancer  MRI  radiomics  treatment response prediction  concurrent chemotherapy and radiation therapy  precision medicine  
Predicting response to immunotherapy in advanced non-small-cell lung cancer using tumor mutational burden radiomic biomarker 期刊论文
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8, 期号: 2, 页码: 10
作者:  He, Bingxi;  Dong, Di;  She, Yunlang;  Zhou, Caicun;  Fang, Mengjie;  Zhu, Yongbei;  Zhang, Henghui;  Huang, Zhipei;  Jiang, Tao;  Tian, Jie;  Chen, Chang
Adobe PDF(5232Kb)  |  收藏  |  浏览/下载：306/54  |  提交时间：2020/08/24
immunotherapy  lung neoplasms  tumor microenvironment  biomarkers  tumor  biostatistics  
Assessing PD-L1 expression in non-small cell lung cancer and predicting responses to immune checkpoint inhibitors using deep learning on computed tomography images 期刊论文
Theranostics, 2020, 卷号: 0, 期号: 0, 页码: 0
作者:  Tian, Panwen;  He, Bingxi;  Dong, Di;  Mu, Wei;  Liu, Kunqin;  Liu, Li;  Zeng, Hao;  Liu, Yujie;  Jiang, Lili;  Zhou, Ping;  Huang, Zhipei;  Li, Weimin;  Tian, Jie
Adobe PDF(1539Kb)  |  收藏  |  浏览/下载：267/112  |  提交时间：2020/10/25
PD-L1 expression  deep learning  computed tomography  immunotherapy  non-small cell lung cancer.